M. Masavuli

发表

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents

A. Sette, G. Maddern, D. Lynn, 2022, Cell Reports Medicine.

COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection

D. Lynn, D. Weiskopf, S. Turville, 2021, medRxiv.

Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus

I. Voskoboinik, Z. Mekonnen, E. Gowans, 2020, Vaccines.

A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses

F. Ryan, P. Monagle, D. Lynn, 2022, medRxiv.

NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice

N. Prow, D. Barouch, J. Hayball, 2019, Science Advances.

Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus

A. Lloyd, D. Bowen, Z. Mekonnen, 2019, Journal of Virology.

Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19

S. Chadban, P. Hurtado, S. Turville, 2022, Kidney International.

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines

Z. Mekonnen, E. Gowans, B. Grubor-Bauk, 2019, Vaccines.

A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines

D. Lynn, F. Ryan, P. Monagle, 2023, Cell Reports Medicine.

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

S. Barry, D. Lynn, F. Ryan, 2021, BMC Medicine.

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C

J. Torresi, E. Gowans, B. Grubor-Bauk, 2017, Front. Microbiol..

Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection

R. Bull, A. Lloyd, Z. Mekonnen, 2019, Front. Cell. Infect. Microbiol..

Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3

Wenbo Yu, J. Torresi, Z. Mekonnen, 2020, Frontiers in Microbiology.

A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice

R. Bull, J. Torresi, E. Gowans, 2019, Front. Immunol..

mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients

S. Chadban, D. Weiskopf, P. Hurtado, 2023, medRxiv.

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19

S. Barry, A. Sette, G. Maddern, 2021, SSRN Electronic Journal.

Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma

K. Mrozik, A. Zannettino, K. Vandyke, 2023, British journal of haematology.

Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine

Z. Mekonnen, B. Grubor-Bauk, D. Wijesundara, 2023, Molecular Therapy: Nucleic Acids.